ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
HEMOGENYX PHARMACEUTICALS PLC: ifrs:AdjustmentsForDepreciationExpense
One fact, its scope and the complete path back to the official record.
Reported value
645.681k{"amount": 645681.0}- Metric
- ifrs:AdjustmentsForDepreciationExpense
- Period
- 2023-01-01 – 2023-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:2138008L93GYU5GN6179:2024-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-23T23:04:53.355718+02:00
Raw response SHA-256
0c5d6c4a8d9962ade23d91dee1fbeea6…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.